Provention Bio Inc. (PRVB) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mail
Get Alerts PRVB Hot Sheet
Join SI Premium – FREE
Provention Bio Inc. (NASDAQ: PRVB) reported Q3 EPS of ($0.43), $0.08 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Provention Bio Inc. (PRVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Williams Trading Downgrades Birkenstock Holding plc (BIRK) to Sell, 'Stock Less Comfortable than the Shoes'
- BMO: 'We view the readthrough as modestly positive for CVSA/STRA'
- Raymond James gets more bullish on Capri amid favorable setup
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
